ClinicalTrials.gg
Drug

Vancomycin clinical trials

Also written Firvanq.

studies test it
176
open now
42
in phase 3
27
first study started
1997

How each study uses Vancomycin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Vancomycin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Approvals

The first approval found in each region, with its record

United States
6 Nov 1964 · VANCOCIN HYDROCHLORIDE · ANDA 060180 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorisations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Vancomycin
111
Vancocin
22
Oral Vancomycin
12
Vancomycin Hydrochloride
10
Vancomycin powder
6

Brand

Firvanq
2

In one entry with another drug

Given together, or one or the other

Vancomycin and gentamycin
2

Studies by the year they started

175 studies that test it; most in 2018 (14); 1 more planned to start later

Studies that test Vancomycin, by start year
YearStudies
19971
20001
20011
20022
20041
20054
20062
20071
20081
20093
20107
20116
201213
20136
20149
20159
20167
201710
201814
201911
20208
202110
202211
202311
202410
20256
202610

By phase

A phase 1/2 study counts in both.

Early Phase 1
4
Phase 1
24
Phase 2
38
Phase 3
27
Phase 4
59
No phase
35

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 13 · Other 163

Mayo Clinic (5) · University of Minnesota (4) · Pfizer (4) · Assiut University (4) · Hamilton Health Sciences Corporation (4) · Medical College of Wisconsin (3) · NYU Langone Health (3) · University of Tennessee (3)

Often tested with

Tested in the same studies.

Cefazolin (9) · Metronidazole (8) · Gentamicins (7) · Tobramycin (7) · Fidaxomicin (6) · Neomycin (6) · Linezolid (6) · Daptomycin (6)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 14, 2 in phase 3

Studies that test Vancomycin, phase 3 first.

Studies

Open first, then newest update. How each study uses Vancomycin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 176

See all 176 studies that test Vancomycin →

Given beside what is tested · 39 — Vancomycin is usual care or a partner of the new treatment

Showing 20 of 39.

As the comparator · 96 — what is tested is compared with Vancomycin

Showing 20 of 96.

Codes

What other systems call Vancomycin · ClinicalTrials.gg INT008395

  • MeSH (NLM) D014640VancomycinConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 6Q205EH1VUVANCOMYCINConfirmed FDA, NLM, Wikidata
  • RxNorm 11124Confirmed FDA, Wikidata
  • Wikidata Q424027vancomycinConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C925VancomycinConfirmed FDA, Wikidata
  • DrugBank DB00512One source Wikidata

Also registered as vancomycin hydrochloride (UNII 71WO621TJD · RxNorm 66955).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.